Alnylam Pharmaceuticals
ALNY
#645
Rank
ยฃ25.09 B
Marketcap
ยฃ194.59
Share price
-0.77%
Change (1 day)
49.70%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of September 2024 : ยฃ2.20 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has ยฃ2.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ1.91 B5.66%
2022-12-31ยฃ1.81 B0.44%
2021-12-31ยฃ1.80 B31.21%
2020-12-31ยฃ1.37 B17.38%
2019-12-31ยฃ1.17 B37.16%
2018-12-31ยฃ0.85 B-31.72%
2017-12-31ยฃ1.25 B146.25%
2016-12-31ยฃ0.50 B-30.33%
2015-12-31ยฃ0.72 B62.94%
2014-12-31ยฃ0.44 B200.21%
2013-12-31ยฃ0.14 B96.17%
2012-12-31ยฃ75.98 M-19.33%
2011-12-31ยฃ94.19 M-37.63%
2010-12-31ยฃ0.15 B-13.16%
2009-12-31ยฃ0.17 B-40.78%
2008-12-31ยฃ0.29 B49.61%
2007-12-31ยฃ0.19 B76.97%
2006-12-31ยฃ0.11 B139.08%
2005-12-31ยฃ46.39 M93.42%
2004-12-31ยฃ23.98 M84.99%
2003-12-31ยฃ12.96 M34.32%
2002-12-31ยฃ9.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.34 B-84.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.78 B 252.36%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.95 B-56.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.24 M-98.54%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ75.05 M-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.14 B 404.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ5.78 B 162.00%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ2.63 B 19.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel